PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $682,228 | -90.7% | 40,901 | -84.5% | 0.00% | -100.0% |
| Q2 2023 | $7,303,032 | +14.2% | 264,411 | -4.9% | 0.00% | 0.0% |
| Q1 2023 | $6,392,528 | +1757.0% | 277,936 | +780.9% | 0.00% | – |
| Q4 2022 | $344,232 | +42.2% | 31,552 | +9.8% | 0.00% | – |
| Q3 2022 | $242,000 | +3.9% | 28,724 | -2.6% | 0.00% | – |
| Q2 2022 | $233,000 | -67.2% | 29,503 | -1.7% | 0.00% | – |
| Q1 2022 | $711,000 | +4.9% | 30,026 | +51.5% | 0.00% | – |
| Q4 2021 | $678,000 | +70.4% | 19,825 | -11.7% | 0.00% | – |
| Q3 2021 | $398,000 | -51.1% | 22,452 | +23.9% | 0.00% | – |
| Q2 2021 | $814,000 | +210.7% | 18,122 | +79.4% | 0.00% | – |
| Q1 2021 | $262,000 | -92.9% | 10,103 | -94.7% | 0.00% | -100.0% |
| Q3 2020 | $3,699,000 | -10.6% | 189,232 | -19.2% | 0.00% | 0.0% |
| Q2 2020 | $4,137,000 | +590.7% | 234,281 | +175.9% | 0.00% | – |
| Q1 2020 | $599,000 | -21.6% | 84,930 | +33.4% | 0.00% | – |
| Q3 2019 | $764,000 | -25.7% | 63,653 | -25.0% | 0.00% | – |
| Q2 2019 | $1,028,000 | +14.7% | 84,849 | +19.0% | 0.00% | – |
| Q1 2019 | $896,000 | +82.9% | 71,313 | -2.3% | 0.00% | – |
| Q2 2018 | $490,000 | +1.2% | 72,964 | +29.6% | 0.00% | – |
| Q1 2018 | $484,000 | – | 56,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |